ClinicalTrials.Veeva

Menu

A Multi-centre Study to Assess the Long-term Performance of the Silent Hip™ in Primary Total Hip Replacement Surgery

DePuy Synthes logo

DePuy Synthes

Status

Terminated

Conditions

Secondary Arthritis
Primary Arthritis

Treatments

Device: Silent™ Hip

Study type

Interventional

Funder types

Industry

Identifiers

NCT01383824
CT09/02

Details and patient eligibility

About

The purpose of this study is to monitor the performance and of the Silent Hip™ in the treatment of patients with hip joint disease requiring a total hip replacement. Patients who enter the study will be evaluated at regular intervals following hip surgery using patient, clinical and x-ray assessments.

Enrollment

89 patients

Sex

All

Ages

Under 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Any subject deemed suitable to receive the Silent™ Hip in combination with the Pinnacle™ acetabular cup system, in accordance with all applicable Instructions For Use, should be considered for entry into this study.

Exclusion criteria

  • Subjects who, in the opinion of the Investigator, have an existing condition/co-morbidity or infection that would compromise their long-term participation and follow-up in this study.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

89 participants in 1 patient group

Silent™ Hip
Other group
Description:
A short cementless, femoral component for use in total hip arthroplasty
Treatment:
Device: Silent™ Hip

Trial contacts and locations

9

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems